The PMHNP is seeing a patient in follow-up. The patient has a diagnosis of schizoaffective disorder and has been taking the second-generation antipsychotic olanzapine for 2 months. The patient appears to be experiencing a distinct improvement in both the positive symptoms of schizophrenia as well as depressive symptoms of major depressive disorder. The NP evaluates for which of the following common adverse drug effects of this medication? A. Weight gain B. Insomnia C. ...
Podzilla Summary coming soon
Sign up to get notified when the full AI-powered summary is ready.
Free forever for up to 3 podcasts. No credit card required.
Listen to This Episode
More from PMHNP Certification Q & A
Pediatric Developmental Assessment
Therapeutic Alliance in a Court-Ordered Patient
Adverse Drug Effects in Psychiatric Treatment
Social Determinants of Health Domains
Get summaries like this every morning.
Free AI-powered recaps of PMHNP Certification Q & A and your other favorite podcasts, delivered to your inbox.
Free forever for up to 3 podcasts. No credit card required.